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Preeclampsia (PE) is a multiorgan 
hypertensive-disorder in pregnancy that 
causes significant maternal-fetal 
mortality and morbidity. The diagnostics 
and therapeutics for PE are limited due 
to its unclear etiology.  Using the UI 
Maternal Fetal Tissue Bank, our lab has 
demonstrated that copeptin is robustly 
predictive of PE. To investigate copeptin 
further, we developed the Rule Out Pre-
Eclampsia Study (ROPE). The ROPE 
study recruits women admitted to Labor 
and Delivery for evaluation of PE. 
Women are admitted for PE evaluation 
at all hours. Research team members 
are not available at all times to obtain 
consent which limits recruitment. Our 
project aimed to develop an electronic 
informed consent (e-IC) that is 
compliant with the Federal Regulation 
for Human Research Protection and is 
easy to use and readily understood by 
study participants. After obtaining IRB 
approval, simulated patients were given 
an iPad on which to read and evaluate 
the e-IC using a validated questionnaire, 
the Quality of Informed Consent (QuIC). 
Based on the QuIC, the e-IC was 
modified and re-tested.  Participants 
demonstrated good comprehension of 
the e-IC as evidence by QuIC scores 
ranging from 61 to 96.  Based on our 
results, the e-IC is an effective and 
efficient method for the Informed 
Consent process. 
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